Factors for Overall Survival in Patients with Skull Base Chordoma: A Retrospective Analysis of 225 Patients

被引:16
|
作者
Tian, Kaibing [1 ]
Zhang, Haoyu [1 ]
Ma, Junpeng [1 ]
Wang, Ke [1 ]
Ru, Xiaojuan [2 ]
Du, Jiang [3 ]
Jia, Guijun [1 ]
Zhang, Liwei [1 ]
Wu, Zhen [1 ]
Zhang, Junting [1 ]
Wang, Liang [1 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Neurosurg Inst, Dept Neuroepidemiol, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Neurosurg Inst, Dept Neuropathol, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Chordoma; Overall survival; Prognostic factor; Skull base; Surgery; CRANIOCERVICAL JUNCTION; INTRACRANIAL CHORDOMAS; CLINICAL ARTICLE; TUMOR RECURRENCE; MANAGEMENT; OUTCOMES; PREDICTORS; FEATURES; DISEASE; AGE;
D O I
10.1016/j.wneu.2016.09.055
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Although a controversial and complex issue, the prognostic factors of skull base chordomas are worth exploring. METHODS: Prognostic factors associated with overall survival (OS) were retrospectively estimated in an individual cohort of skull base chordomas prospectively maintained for 10 years by a Kaplan-Meier method and univariate Cox proportional hazards model. Multivariate analysis by Cox regression analysis was performed to identify the independent prognostic factors. A nomogram was then formulated by R software based on the results. RESULTS: A total of 180 primary patients and 45 recurrent cases were included, with a mean follow-up period of 43.7 months (range, 4-127 months). The OS of the primary group at 5 years and 7 years was 84% and 78%, and the mean OS was 103.8 months, which was significantly longer than the recurrent group, in which the mean postrecurrent OS was 68.4 months. In the primary group, preoperative Karnofsky Performance Status (KPS) score (P = 0.004) and a decline of perioperative KPS score (P = 0.015) were identified as independent predictors of OS. A nomogram was contracted to predict 5-year, and 7-year OS, which was well calibrated and had good discriminative ability (adjusted Harrell C statistic, 0.74). In the recurrent group, visual deficit was verified as an independent risk factor associated with postrecurrent OS (P = 0.014). CONCLUSIONS: Both pathologic and perioperative KPS score evaluations are significant in OS prediction of both primary and recurrent cases. The nomogram for primary lesions, consisting of preoperative functional status and its perioperative changes, appears useful for risk stratification of long-term survival.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 50 条
  • [1] Clinical features and surgical outcomes of patients with skull base chordoma: a retrospective analysis of 238 patients
    Wang, Liang
    Wu, Zhen
    Tian, Kaibing
    Wang, Ke
    Li, Da
    Ma, Junpeng
    Jia, Guijun
    Zhang, Liwei
    Zhang, Junting
    JOURNAL OF NEUROSURGERY, 2017, 127 (06) : 1257 - 1267
  • [2] Factors for tumor progression in patients with skull base chordoma
    Wang, Liang
    Tian, Kaibing
    Wang, Ke
    Ma, Junpeng
    Ru, Xiaojuan
    Du, Jiang
    Jia, Guijun
    Zhang, Liwei
    Wu, Zhen
    Zhang, Junting
    CANCER MEDICINE, 2016, 5 (09): : 2368 - 2377
  • [3] Proposal and Validation of a Basic Progression Scoring System for Patients with Skull Base Chordoma
    Ma, Jun-Peng
    Tian, Kai-Bing
    Wang, Liang
    Wang, Ke
    Li, Da
    Yang, Yang
    Du, Jiang
    Ru, Xiao-Juan
    Zhang, Li-Wei
    Wu, Zhen
    Zhang, Jun-Ting
    WORLD NEUROSURGERY, 2016, 91 : 409 - 418
  • [4] Treatment and Outcome of Patients with Skull Base Chordoma: A Meta-analysis
    Amit, Moran
    Na'ara, Shorook
    Binenbaum, Yoav
    Billan, Salem
    Sviri, Gil
    Cohen, Jacob T.
    Gil, Ziv
    JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE, 2014, 75 (06) : 383 - 390
  • [5] The utility of inflammatory biomarkers in predicting overall survival and recurrence in skull base chordoma
    Hoppe, Meagan
    Gersey, Zachary C.
    Muthiah, Nallammai
    Abdallah, Hussein M.
    Plute, Tritan
    Abou-Al-Shaar, Hussam
    Wang, Eric W.
    Snyderman, Carl H.
    Zenonos, Georgios A.
    Gardner, Paul A.
    NEUROSURGICAL FOCUS, 2024, 56 (05)
  • [6] Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center
    Meng, Tong
    Yin, Huabin
    Li, Bo
    Li, Zhenxi
    Xu, Wei
    Zhou, Wang
    Cheng, Mo
    Wang, Jing
    Zhou, Lei
    Yang, Xinghai
    Liu, Tielong
    Yan, Wangjun
    Song, Dianwen
    Xiao, Jianru
    NEURO-ONCOLOGY, 2015, 17 (05) : 725 - 732
  • [7] Chondrosarcoma and Chordoma of the Skull Base and Spine: Implication of Tumor Location on Patient Survival
    Vuong, Huy Gia
    Dunn, Ian F.
    WORLD NEUROSURGERY, 2022, 162 : E635 - E639
  • [8] Skull Base Chordoma and Chondrosarcoma: Influence of Clinical and Demographic Factors on Prognosis: A SEER Analysis
    Bohman, Leif-Erik
    Koch, Matthew
    Bailey, Robert L.
    Alonso-Basanta, Michelle
    Lee, John Y. K.
    WORLD NEUROSURGERY, 2014, 82 (05) : 806 - 814
  • [9] Determinants of quality of life in patients with skull base chordoma Clinical article
    Diaz, Roberto Jose
    Maggacis, Nicole
    Zhang, Shudong
    Cusimano, Michael D.
    JOURNAL OF NEUROSURGERY, 2014, 120 (02) : 528 - 537
  • [10] Application of nomograms to predict overall and cancer-specific survival in patients with chordoma
    Zheng Weipeng
    Huang Yuanping
    Guan Tianwang
    Lu Songfang
    Yao Liquan
    Wu Senrui
    Chen Haoyi
    Wang Ning
    Liang YingJie
    Xiao Wende
    Jiang Xin
    Wen Shifeng
    JOURNAL OF BONE ONCOLOGY, 2019, 18